FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198647593> ?p ?o ?g. }

• W3198647593 abstract "Slow uptake of sacubitril/valsartan in patients with heart failure with reduced ejection fraction has been reported, which may negatively impact clinical outcomes. We characterized prior authorization (PA) burden, prescription copayment, and utilization of sacubitril/valsartan by insurance plan type to identify potential barriers to its use.We conducted a national population-level, cross-sectional study using PA data from an insurance coverage website accessed in March 2019 and IQVIA National Prescription Audit data from August 2018 to July 2019. Primary outcomes were proportion of plans requiring PA, frequency of specific PA criteria, number of sacubitril/valsartan prescriptions, and copayments per insurance plan type.Overall, 48.1% (1394/2896) of insurance plans required PA for sacubitril/valsartan. Fewer Medicare (27.7%) than commercial (57.2%) plans required PA (P<0.001). For both plan types, the most frequently required PA criteria were ejection fraction (71.6%, 90.9%) and New York Heart Association class (60.4%, 90.8%) for Medicare and commercial plans, respectively. Copayment amounts varied by plan type, with more sacubitril/valsartan prescriptions for commercial plans not requiring a patient copayment (32.4%) compared with Medicare plans (19.3%; P<0.001). There were 814 437 sacubitril/valsartan prescriptions for Medicare and 822 292 for commercial plans dispensed from August 2018 to July 2019. Based on estimated heart failure with reduced ejection fraction populations for each plan type, 4-fold more sacubitril/valsartan prescriptions were dispensed in commercial than in Medicare plans (820 versus 215 prescriptions/1000 individuals in the heart failure with reduced ejection fraction population). The estimated proportion of heart failure with reduced ejection fraction patients prescribed sacubitril/valsartan was 3.6% (1.5%-6.8%) for Medicare and 13.7% (4.9%-31.8%) for commercial plan populations.Despite commercial plans having greater PA requirements than Medicare, population-adjusted use of sacubitril/valsartan was higher in commercial plans. Given that commercial plans had more prescriptions with low copayments than Medicare, copayment policies may be more influential on sacubitril/valsartan use than its PA policies. Low sacubitril/valsartan use in both plan types highlights the multifactorial nature of medication underutilization that includes factors beyond the drug policies that we evaluated." @default.
• W3198647593 created "2021-09-13" @default.
• W3198647593 creator A5004859111 @default.
• W3198647593 creator A5012255788 @default.
• W3198647593 creator A5033092324 @default.
• W3198647593 creator A5059547803 @default.
• W3198647593 creator A5063955986 @default.
• W3198647593 creator A5078559909 @default.
• W3198647593 creator A5086385568 @default.
• W3198647593 date "2021-09-01" @default.
• W3198647593 modified "2023-10-16" @default.
• W3198647593 title "Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction" @default.
• W3198647593 cites W2010691204 @default.
• W3198647593 cites W2019576938 @default.
• W3198647593 cites W2113698123 @default.
• W3198647593 cites W2399407199 @default.
• W3198647593 cites W2468095632 @default.
• W3198647593 cites W2469273851 @default.
• W3198647593 cites W2601058970 @default.
• W3198647593 cites W2759629908 @default.
• W3198647593 cites W2784082460 @default.
• W3198647593 cites W2797114455 @default.
• W3198647593 cites W2913705661 @default.
• W3198647593 cites W2972341500 @default.
• W3198647593 cites W2988422427 @default.
• W3198647593 doi "https://doi.org/10.1161/circoutcomes.120.007665" @default.
• W3198647593 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34465124" @default.
• W3198647593 hasPublicationYear "2021" @default.
• W3198647593 type Work @default.
• W3198647593 sameAs 3198647593 @default.
• W3198647593 citedByCount "8" @default.
• W3198647593 countsByYear W31986475932022 @default.
• W3198647593 countsByYear W31986475932023 @default.
• W3198647593 crossrefType "journal-article" @default.
• W3198647593 hasAuthorship W3198647593A5004859111 @default.
• W3198647593 hasAuthorship W3198647593A5012255788 @default.
• W3198647593 hasAuthorship W3198647593A5033092324 @default.
• W3198647593 hasAuthorship W3198647593A5059547803 @default.
• W3198647593 hasAuthorship W3198647593A5063955986 @default.
• W3198647593 hasAuthorship W3198647593A5078559909 @default.
• W3198647593 hasAuthorship W3198647593A5086385568 @default.
• W3198647593 hasBestOaLocation W31986475931 @default.
• W3198647593 hasConcept C126322002 @default.
• W3198647593 hasConcept C159110408 @default.
• W3198647593 hasConcept C2426938 @default.
• W3198647593 hasConcept C2775999527 @default.
• W3198647593 hasConcept C2776291444 @default.
• W3198647593 hasConcept C2777387769 @default.
• W3198647593 hasConcept C2778198053 @default.
• W3198647593 hasConcept C2778858636 @default.
• W3198647593 hasConcept C71924100 @default.
• W3198647593 hasConcept C78085059 @default.
• W3198647593 hasConcept C84393581 @default.
• W3198647593 hasConceptScore W3198647593C126322002 @default.
• W3198647593 hasConceptScore W3198647593C159110408 @default.
• W3198647593 hasConceptScore W3198647593C2426938 @default.
• W3198647593 hasConceptScore W3198647593C2775999527 @default.
• W3198647593 hasConceptScore W3198647593C2776291444 @default.
• W3198647593 hasConceptScore W3198647593C2777387769 @default.
• W3198647593 hasConceptScore W3198647593C2778198053 @default.
• W3198647593 hasConceptScore W3198647593C2778858636 @default.
• W3198647593 hasConceptScore W3198647593C71924100 @default.
• W3198647593 hasConceptScore W3198647593C78085059 @default.
• W3198647593 hasConceptScore W3198647593C84393581 @default.
• W3198647593 hasIssue "9" @default.
• W3198647593 hasLocation W31986475931 @default.
• W3198647593 hasLocation W31986475932 @default.
• W3198647593 hasOpenAccess W3198647593 @default.
• W3198647593 hasPrimaryLocation W31986475931 @default.
• W3198647593 hasRelatedWork W2413467082 @default.
• W3198647593 hasRelatedWork W2604998822 @default.
• W3198647593 hasRelatedWork W2747380082 @default.
• W3198647593 hasRelatedWork W2919008909 @default.
• W3198647593 hasRelatedWork W2987185485 @default.
• W3198647593 hasRelatedWork W3028944270 @default.
• W3198647593 hasRelatedWork W3209020026 @default.
• W3198647593 hasRelatedWork W4224986348 @default.
• W3198647593 hasRelatedWork W4283769466 @default.
• W3198647593 hasRelatedWork W4307774018 @default.
• W3198647593 hasVolume "14" @default.
• W3198647593 isParatext "false" @default.
• W3198647593 isRetracted "false" @default.
• W3198647593 magId "3198647593" @default.
• W3198647593 workType "article" @default.